ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1447

Positive Power Doppler Signal Increases the Risk of Clinical Flare of Patients with Juvenile Idiopathic Arthritis in Clinical Remission: A Prospective Study

Vanessa B Miotto e Silva1, Octavio Peracchi2, Claudio A. Len3, Sônia A.V. Mitraud4, Rita NV Furtado5, Jamil Natour6 and Maria Teresa Terreri7, 1Pediatrics, Universidade Federal de São Paulo / UNIFESP, São Paulo, Brazil, 2Pediatric Rheumatology, Assistent Doctor, Sao Paulo, Brazil, 3Pediatrics, Universidade Federal de São Paulo, São Paulo,, Brazil, 4Radiology and Diagnostic Imaging, Escola Paulista de Medicina/ Universidade Federal de São Paulo (EPM/UNIFESP), São Paulo, Brazil, 5Medicine, Universidade Federal de Sao Paulo, Sao Paulo, Brazil, 6Rheumatology Division, Federal University of Sao Paulo, Sao Paulo, Brazil, 7Pediatrics, Universidade Federal de Sao Paulo, São Paulo, Brazil

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Doppler ultrasound, juvenile idiopathic arthritis (JIA) and synovitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects Posters. Juvenile Arthritis and Miscellaneous Rheumatic Diseases

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Prior ultrasound (US) studies in patients with juvenile idiopathic arthritis (JIA) in clinical remission have demonstrated the presence of subclinical synovitis. However, the significance of subclinical synovitis and positive power Doppler (PD) signal in these patients  is still not well understood. The objectives of this study were to evaluate possible factors associated with clinical flare over a 30-month evaluation in a group of patients with JIA in remission and assess if the presence of US features could predict disease flares.

Methods: In this two years longitudinal, single-center study we performed clinical, laboratory (every 6 months) and US evaluations (initial, after 12 and 24 months) in 35 JIA patients in clinical remission according to Wallace criteria (34 joints/60 articular recesses).  US parameters included synovial hypertrophy, PD signal and evidence of bone erosions. Subclinical synovitis was defined by the presence of synovial hypertrophy and/or positive PD signal. Flare was defined according to Wallace criteria.

Results: Of the 35 patients (80% female), 14 (40%) had persistent oligoarticular, 12 (34.3%) extended oligoarticular and 9 (25.7%) polyarticular JIA. Twenty patients (57.1%) were antinuclear antibodies (ANA) positive and none were rheumatoid factor (RF) positive. The mean age was 11.6 ± 3.8 years, the mean age of onset of JIA was 4.4 ± 3.2 years and the mean disease duration was 7.1 ± 3.5 years. Twenty-six (74.3%) patients were in remission on treatment and 9 (25.7%) were in remission off medication, for a median of 1.9 years. Twenty (57.1%) patients flared during the 30 months follow-up. Knees and ankles were most commonly affected. Eighteen (90%) were on treatment at the time of clinical flare. Of the 20 clinical flare patients, 7 (35%) had subclinical synovitis, 10 (50%) had synovial hypertrophy and 2 (10%) had positive PD signal at the time of flare. A Cox regression  analysis found that both a positive PD signal (p=0.046) and the use of medications (p <0.001) were significantly associated with flare, and the risk of flare in patients with a positive PD signal was five times greater than in patients without  a PD signal. Patients who were in remission on treatment showed a 14 times higher risk of clinical flare than patients off treatment.

Conclusion: The presence of subclinical synovitis detected by US in JIA patients in clinical remission did not predict flare of the disease. On the other hand, a positive PD signal showed a greater risk of JIA clinical flare. The remission on medication was also a risk factor for JIA flare. Patients in remission on treatment with a positive PD signal should be cautiously tapered due to the higher risk of clinical flares.


Disclosure: V. B. Miotto e Silva, None; O. Peracchi, None; C. A. Len, None; S. A. V. Mitraud, None; R. N. Furtado, None; J. Natour, None; M. T. Terreri, None.

To cite this abstract in AMA style:

Miotto e Silva VB, Peracchi O, Len CA, Mitraud SAV, Furtado RN, Natour J, Terreri MT. Positive Power Doppler Signal Increases the Risk of Clinical Flare of Patients with Juvenile Idiopathic Arthritis in Clinical Remission: A Prospective Study [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/positive-power-doppler-signal-increases-the-risk-of-clinical-flare-of-patients-with-juvenile-idiopathic-arthritis-in-clinical-remission-a-prospective-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/positive-power-doppler-signal-increases-the-risk-of-clinical-flare-of-patients-with-juvenile-idiopathic-arthritis-in-clinical-remission-a-prospective-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology